Literature DB >> 4960423

The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of colorectal carcinoma.

W D Holden, W J Dixon, J W Kuzma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4960423      PMCID： PMC1617466          DOI： 10.1097/00000658-196704000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  8 in total

1.  A study of the use of triethylenethiophosphoramide as an adjuvant to surgery in the treatment of colorectal cancer.

Authors:  W D HOLDEN; W J DIXON
Journal:  Cancer Chemother Rep       Date:  1962-02

2.  Clinical and experimental observations of the occurrence and fate of tumor cells in the blood stream.

Authors:  G E MOORE; A SANDBERG; J R SCHUBARG
Journal:  Ann Surg       Date:  1957-10       Impact factor: 12.969

3.  The effect of cancer inhibitor drugs on the take of Walker carcinosarcoma 256 in rats.

Authors:  G O MCDONALD; E P CRUZ; W H COLE
Journal:  Surg Forum       Date:  1957

4.  A role for chemotherapy as an adjunct to surgery.

Authors:  D M SHAPIRO; R A FUGMANN
Journal:  Cancer Res       Date:  1957-12       Impact factor: 12.701

5.  The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma.

Authors:  E R FISHER; R B TURNBULL
Journal:  Surg Gynecol Obstet       Date:  1955-01

6.  Evaluation of recurrence in gastric adenocarcinoma patients.

Authors:  J W Kuzma; W J Dixon
Journal:  Cancer       Date:  1966-05       Impact factor: 6.860

7.  The prophylactic treatment of malignant disease with nitrogen mustard and triethylenethiophosphoramide (thio-TEPA).

Authors:  G O MCDONALD; C LIVINGSTON; C F BOYLES; W H COLE
Journal:  Ann Surg       Date:  1957-05       Impact factor: 12.969

8.  Prophylactic treatment of cancer; the use of chemotherapeutic agents to prevent tumor metastasis.

Authors:  E P CRUZ; G O MCDONALD; W H COLE
Journal:  Surgery       Date:  1956-08       Impact factor: 3.982
  8 in total
  9 in total

1.  Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice.

Authors:  K Yamada
Journal:  Gastroenterol Jpn       Date:  1987-10

2.  Adjuvant treatment in colorectal cancer: an update.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

3.  Carcinoma of the colon and rectum.

Authors:  C K McSherry; G N Cornell; F Glenn
Journal:  Ann Surg       Date:  1969-04       Impact factor: 12.969

4.  Use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma: ten-year follow-up.

Authors:  W J Dixon; W P Longmire; W D Holden
Journal:  Ann Surg       Date:  1971-01       Impact factor: 12.969

5.  Cancer of the colon.

Authors:  E B Smith
Journal:  J Natl Med Assoc       Date:  1973-03       Impact factor: 1.798

6.  Adjuvant treatment of colorectal cancer.

Authors:  J S Nystrom; J R Bateman; J Weiner
Journal:  West J Med       Date:  1977-02

7.  Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer.

Authors:  S Fujimoto; T Akao; B Itoh; I Koshizuka; K Koyano
Journal:  Ann Surg       Date:  1977-04       Impact factor: 12.969

8.  Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report).

Authors:  M Niimoto; T Hattori; R Tamada; K Sugimachi; K Inokuchi; N Ogawa
Journal:  Jpn J Surg       Date:  1987-09

9.  Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication.

Authors:  J Bancewicz; K C Calman; S G Macpherson; C S McArdle; J G McVie; M Soukop
Journal:  J R Soc Med       Date:  1980-03       Impact factor: 18.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.